PBH logo

Prestige Consumer Healthcare Inc.

PBH
Healthcare|Medical - Pharmaceuticals|US
$42.98
-1.34 (-3.02%)
DCF Value
$259.88
Graham Number
$54.85
Cash / Share
$0.98

About

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.

Stock Price

-30.0%(1Y)
1M
-10.2%
3M
-21.6%
6M
-18.2%
YTD
-30.3%
1Y
-28.9%
3Y
-27.2%
5Y
-31.6%

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

Key Facts

Market Cap$2.04B
Employees890 (+48% YoY)
CEORonald Lombardi
IPO DateFeb 10, 2005
Beta0.34
52-Week Range$41.77 – $71.07
Avg Volume563,106
ExchangeNYSE

Ownership

Float98.5%
Shares Outstanding47.4M

Recent Insider Trades

ZIER DAWN M.AWARD
Aug 4, 20262,981 shares
Kelly John F.AWARD
Aug 4, 20262,981 shares
DArecca JamesAWARD
Aug 4, 20262,981 shares
Clark Celeste A.AWARD
Aug 4, 20262,981 shares
BYOM JOHN EAWARD
Aug 4, 20262,981 shares

Peers

ATECAlphatec Holdings, Inc.
$1.15B
CONConcentra Group Holdings Parent, Inc.
$5.38B
CPRXCatalyst Pharmaceuticals, Inc.
$3.85B
HTFLHeartflow, Inc. Common Stock
$4.56B
ICUIICU Medical, Inc.
$4.30B
IRONDisc Medicine, Inc.
$3.03B
LEGNLegend Biotech Corporation
$4.33B
LIVNLivaNova PLC
$4.96B
Data last updated: Nov 9, 2026, 04:27 AM